129 related articles for article (PubMed ID: 37580811)
1. Comparison between clinical evaluations and laboratory findings and the impact of biofilm on antimicrobial susceptibility in vitro in canine otitis externa.
Luciani L; Stefanetti V; Rampacci E; Gobbi P; Valentini L; Capuozzo R; Passamonti F
Vet Dermatol; 2023 Dec; 34(6):586-596. PubMed ID: 37580811
[TBL] [Abstract][Full Text] [Related]
2. Biofilm production by pathogens associated with canine otitis externa, and the antibiofilm activity of ionophores and antimicrobial adjuvants.
Chan WY; Hickey EE; Page SW; Trott DJ; Hill PB
J Vet Pharmacol Ther; 2019 Nov; 42(6):682-692. PubMed ID: 31503362
[TBL] [Abstract][Full Text] [Related]
3. Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs.
Zamankhan Malayeri H; Jamshidi S; Zahraei Salehi T
Vet Res Commun; 2010 Jun; 34(5):435-44. PubMed ID: 20526674
[TBL] [Abstract][Full Text] [Related]
4. Determination of minimum inhibitory concentrations for silver sulfadiazine and other topical antimicrobial agents against strains of Pseudomonas aeruginosa isolated from canine otitis externa.
von Silva-Tarouca MSE; Wolf G; Mueller RS
Vet Dermatol; 2019 Apr; 30(2):145-e42. PubMed ID: 30663140
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.
Pye CC; Yu AA; Weese JS
Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa.
Chan WY; Hickey EE; Khazandi M; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2020 Apr; 31(2):138-145. PubMed ID: 31710159
[TBL] [Abstract][Full Text] [Related]
7. Identification and antibiotic susceptibility of bacterial isolates from dogs with otitis externa in Australia.
Bugden DL
Aust Vet J; 2013; 91(1-2):43-6. PubMed ID: 23356371
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa.
Chan WY; Hickey EE; Khazandi M; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2018 Apr; 29(2):149-e57. PubMed ID: 29363210
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of thyme oil, oregano oil, thymol and carvacrol against sensitive and resistant microbial isolates from dogs with otitis externa.
Sim JXF; Khazandi M; Chan WY; Trott DJ; Deo P
Vet Dermatol; 2019 Dec; 30(6):524-e159. PubMed ID: 31566822
[TBL] [Abstract][Full Text] [Related]
10. Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa.
Hariharan H; Coles M; Poole D; Lund L; Page R
Can Vet J; 2006 Mar; 47(3):253-5. PubMed ID: 16604982
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial effects of chitosan-based hydrogels containing Trachyspermum ammi essential oil on pathogens isolated from dogs with otitis externa.
Niaraki NJ; Jamshidi S; Fasaei BN; Joghataei SM
BMC Vet Res; 2024 Apr; 20(1):130. PubMed ID: 38561827
[TBL] [Abstract][Full Text] [Related]
12. Antibiofilm activity of silver nanoparticles against biofilm forming Staphylococcus pseudintermedius isolated from dogs with otitis externa.
Seo M; Oh T; Bae S
Vet Med Sci; 2021 Sep; 7(5):1551-1557. PubMed ID: 34156766
[TBL] [Abstract][Full Text] [Related]
13. The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.
Pietschmann S; Meyer M; Voget M; Cieslicki M
Vet Dermatol; 2013 Aug; 24(4):439-45, e96-7. PubMed ID: 23721182
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial effect of N-acetylcysteine on common canine otitis externa isolates.
May ER; Conklin KA; Bemis DA
Vet Dermatol; 2016 Jun; 27(3):188-e47. PubMed ID: 27122224
[TBL] [Abstract][Full Text] [Related]
15. New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa.
Kiss G; Radványi S; Szigeti G
J Small Anim Pract; 1997 Feb; 38(2):51-6. PubMed ID: 9065882
[TBL] [Abstract][Full Text] [Related]
16. The stability and in vitro antibacterial efficacy of enrofloxacin and gentamicin solutions against Staphylococcus pseudintermedius over 28 days.
Park S; Oh T; Bae S
Vet Dermatol; 2023 Feb; 34(1):28-32. PubMed ID: 36221863
[TBL] [Abstract][Full Text] [Related]
17. Carriage of
Lee GY; Lee HH; Hwang SY; Hong J; Lyoo KS; Yang SJ
J Vet Sci; 2019 Mar; 20(2):e6. PubMed ID: 30944529
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa.
Mekić S; Matanović K; Šeol B
Vet Rec; 2011 Jul; 169(5):125. PubMed ID: 21742683
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial effect of N-acetylcysteine in combination with antimicrobials on common canine otitis externa bacterial isolates.
May ER; Ratliff BE; Bemis DA
Vet Dermatol; 2019 Dec; 30(6):531-e161. PubMed ID: 31670428
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.
Chan WY; Khazandi M; Hickey EE; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2019 Apr; 30(2):133-e38. PubMed ID: 30548715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
